The New York-based firm is scrutinizing the sale of Nuvalent to GSK plc for $124.00 per share, alongside the acquisition of Payoneer Global by Nuvei for $7.40 per share. Additionally, the investigation covers the merger between Dana Incorporated and Eaton Corporation, where Dana shareholders are set to retain approximately 49.9% of the combined entity. Attorneys Daniel Sadeh and Zachary Halper argue that these deals may favor insiders at the expense of ordinary shareholders.

Halper Sadeh is currently seeking to secure increased consideration and expanded disclosures for investors involved in these transactions. The firm operates on a contingent fee basis, asserting that clients will incur no out-of-pocket expenses while pursuing potential relief or corporate reforms. These actions follow the firm’s history of litigating securities fraud and corporate misconduct cases on an international scale.